North Carolina to Return Management of State Health Plan to Blue Cross Blue Shield Starting 2028
The North Carolina health plan covers approximately 740,000 teachers, public employees, retirees, and their families. The state government pays for medical expenses and hires a third-party administrator (TPA) responsible for network building, price negotiation, and claims processing. In 2022, the state government transferred the contract from Blue Cross Blue Shield of NC, which had served for over 40 years, to Aetna, with the contract set to expire at the end of 2027. Aetna's annual management fee is about $91 million.
Aetna's parent company is CVS Health, which also serves as the pharmacy benefits manager, creating a dual role in healthcare and pharmaceuticals. Its performance guarantee penalty cap is only about $40 million and does not cover specialty drugs or claims over $250,000. The state government announced this month that it will switch back to BCBSNC, expecting to save about $1 billion over three years. The new contract will cover medical management and pharmacy benefits, with additional agreements for UNC Health and Novant Health as preferred providers.
In market mechanisms, the state government acts as a major buyer, promoting contract switches through re-bidding and stricter requirements. Funds will flow from national TPAs to the locally dominant BCBSNC, benefiting insurance companies and designated healthcare systems with strong local hospital negotiation power, while Aetna/CVS will face pressure due to losing a long-term contract amid conflicts and performance disputes.
Source: Public Information
ABAB AI Insight
North Carolina has previously made multiple adjustments to the management of large public health plans. Historically, Blue Cross Blue Shield of NC maintained network and pricing advantages due to its 40-plus years of local dominance, while the shift to Aetna in 2022 reflected a decision to pursue the scale benefits of a national TPA. Previous issues with weakened performance guarantees in similar public procurements had led to cost overruns.
In terms of capital pathways, the state government mobilizes taxpayer and employee premium resources by canceling the first round of bidding and strengthening minimum requirements, forcing suppliers to offer better terms. CVS Health had simultaneously controlled both medical TPA and pharmacy management to achieve internal synergy, but ultimately was replaced due to conflicts of interest and insufficient penalty caps, with funds being redirected to a single local supplier in exchange for deeper discounts and network control.
Similar to Mark Cuban's previous public questioning of the vertical integration of large PBMs and insurance companies, current state-level health plans in the U.S. are transitioning from decentralized management by national TPAs to concentration among strong local suppliers. BCBSNC's acquisition of both medical and pharmacy contracts strengthens its control in the North Carolina market.
This essentially represents a restructuring of the industry chain: public procurers break the pricing power distribution between national players and local hospitals through re-bidding. The mechanism allows local dominant suppliers to achieve better unit price negotiations based on geographical and historical relationships, shifting capital from a high management fee and low constraint model to a structure with stronger performance binding and network optimization, thereby reducing overall healthcare spending and minimizing potential conflicts arising from vertical integration.
ABAB News · Cognitive Law
Market vacancies prove that risk is not unbuyable, but that buyers are not bidding correctly.
Local monopoly network > promised discounts from national scale TPAs.
Vertical integration reduces internal costs but amplifies external costs of data conflicts.